C4 Therapeutics Inc (NAS:CCCC)
$ 4.115 +0.10 (+2.5%) Market Cap: 506.25 Mil Enterprise Value: 309.44 Mil PE Ratio: 0 PB Ratio: 2.05 GF Score: 49/100

C4 Therapeutics, Inc Annual Shareholders Meeting Transcript

Jun 24, 2026 / 12:30PM GMT
Release Date Price: $4.25 (+0.71%)
Operator

Good day, and welcome to the C4 Therapeutics, Inc., 2026 Annual Meeting of Stockholders. I would now like to turn the conference over to Ronald Cooper, Chairman of the company's Board of Directors, to proceed with the 2026 Annual Meeting of Stockholders. Mr. Cooper, please go ahead.

Ronald Cooper
C4 Therapeutics, Inc - Independent Chairman of the Board

Good morning, ladies and gentlemen. On behalf of the Board of Directors, I welcome you to the 2026 Annual Meeting of Stockholders of C4 Therapeutics, Inc. I'm Ronald Cooper, Chairman of the Board, and I'll be acting as Chairman of this meeting. Shagha Russell, C4T's General Counsel and Secretary, will be acting as Secretary of the meeting. At this time, I'd like to call the meeting to order, and I declare the polls for each matter to be voted on at this meeting now open.

In attendance today are other members of C4T's Board of Directors and executive management team, including Andrew Hirsch, C4T's President and Chief Executive Officer; Kendra Adams, C4T's Chief Financial Officer and Head of Corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot